Nowak P, Rossi M, Kowalski A. "Method for the Synthesis of 3-(5-Nitrofuran-2-yl)-1-(p-tolyl)-1H-pyrazole-4-carbaldehyde" [P]. European Patent, EP 3231274 A1, 2019-01-26.
发明人唐晓军,罗永刚,陈志强. "A Process for Preparing High-Purity 3-(5-Nitrofuran-2-yl)-1-(p-tolyl)-1H-pyrazole-4-carbaldehyde" [P]. 中国发明专利, 专利号 CN 115527534 A, 授权公告日 2018-10-04.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Talanta, 2021, 825, 9753-9776.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chem., 2019, 346, 1626-1653.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of 3-(5-Nitrofuran-2-yl)-1-(p-tolyl)-1H-pyrazole-4-carbaldehyde Using HRMS and NMR". Molecules, 2015, 1290, (12), 3761-3768.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Food Chem., 2016, 1050, (6), 3974-3994.